Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells
- PMID: 2445889
- PMCID: PMC2189651
- DOI: 10.1084/jem.166.5.1484
Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells
Abstract
A panning method has been developed to enrich Langerhans cells (LC) from murine epidermis. In standard culture media, the enriched populations progressively lose viability over a 3-d interval. When the cultures are supplemented with keratinocyte-conditioned medium, LC viability is improved and the cells increase in size and number of dendritic processes. Accessory function, as monitored by stimulating activity in the mixed lymphocyte reaction (MLR), increases at least 10-20-fold. The conditioned media of stimulated macrophages and T cells also support the viability and maturation of cultured LC. A panel of purified cytokines has been tested, and only granulocyte/macrophage colony-stimulating factor (GM-CSF) substitutes for bulk-conditioned medium. The recombinant molecule exhibits half-maximal activity at 5 pM. Without activity are: IL-1-4; IFN-alpha/beta/gamma; cachectin/TNF; M- and G-CSF. A rabbit anti-GM-CSF specifically neutralizes the capacity of keratinocyte-conditioned medium to generate active LC. However, GM-CSF is not required for LC function during the MLR itself. We conclude that the development of immunologically active LC in culture is mediated by GM-CSF. The observation that these dendritic cells do not respond to lineage-specific G- and M-CSFs suggests that LC represent a distinct myeloid differentiation pathway. Because GM-CSF can be made by nonimmune cells and can mediate the production of active dendritic cells, this cytokine provides a T-independent mechanism for enhancing the sensitization phase of cell-mediated immunity.
Similar articles
-
Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells.J Exp Med. 1988 Feb 1;167(2):700-5. doi: 10.1084/jem.167.2.700. J Exp Med. 1988. PMID: 3279156 Free PMC article.
-
Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to granulocyte/macrophage colony-stimulating factor, without inducing their functional maturation.J Exp Med. 1990 Jan 1;171(1):159-71. doi: 10.1084/jem.171.1.159. J Exp Med. 1990. PMID: 2404080 Free PMC article.
-
Granulocyte macrophage--colony-stimulating factor (GM-CSF) decreases CD1a expression by human Langerhans cells and increases proliferation in the mixed epidermal cell-lymphocyte reaction (MELR).J Invest Dermatol. 1990 Sep;95(3):359-62. doi: 10.1111/1523-1747.ep12485134. J Invest Dermatol. 1990. PMID: 1696605
-
Cytokines amplify the function of accessory cells.Immunol Lett. 1988 Mar;17(3):197-202. doi: 10.1016/0165-2478(88)90028-4. Immunol Lett. 1988. PMID: 3286486 Review.
-
The nature and action of granulocyte-macrophage colony stimulating factors.Blood. 1980 Dec;56(6):947-58. Blood. 1980. PMID: 7002232 Review.
Cited by
-
Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1.Blood. 2012 May 31;119(22):5182-90. doi: 10.1182/blood-2011-09-382200. Epub 2012 Apr 17. Blood. 2012. PMID: 22510877 Free PMC article. Clinical Trial.
-
Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing.J Exp Med. 1992 Jun 1;175(6):1717-28. doi: 10.1084/jem.175.6.1717. J Exp Med. 1992. PMID: 1588289 Free PMC article. Clinical Trial.
-
Site-specific regulation of tissue dendritic cell function by granulocyte-macrophage colony-stimulating-factor.Immunology. 2004 Dec;113(4):482-90. doi: 10.1111/j.1365-2567.2004.01981.x. Immunology. 2004. PMID: 15554926 Free PMC article.
-
Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance.Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):351-8. doi: 10.1073/pnas.231606698. Epub 2002 Jan 2. Proc Natl Acad Sci U S A. 2002. PMID: 11773639 Free PMC article. Review.
-
Adoptive transfer of dendritic cells modulates immunogenesis and tolerogenesis in a neonatal model of murine cutaneous leishmaniasis.Kinetoplastid Biol Dis. 2005 Jan 25;4:2. doi: 10.1186/1475-9292-4-2. eCollection 2005. Kinetoplastid Biol Dis. 2005. PMID: 15670331 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources